Clinical trial
Using Iron With Procrit in Advanced Lung Cancer Patients With…
NCT00481624 · University of Louisville, Other · Withdrawn
Key facts
| NCT number | NCT00481624 |
|---|---|
| Title | Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia |
| Official title | A Phase II Trial Using Intravenous Iron in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia Treated With 120,000 Units Epoetin Alfa Every Three Weeks |
| Acronym | Procrit |
| Lead sponsor | University of Louisville, Other |
| Collaborators | James Graham Brown Cancer Center |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Epoetin Alfa plus Iron |
| Enrollment | 0 |
| Start date | May 1, 2007 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Jun 4, 2007 |
| Last update posted | Mar 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: